Please click
here
if you are not redirected within a few seconds.
Skip to content
Intended for Healthcare Professionals
Top Menu
Top Menu Right
Register
Login
Search for:
All
All
Drugs
Medical Applications
Medical Calculators
Dilutions
Lab Values
Infectious Diseases
Oncology
Renal
Abbreviations
Acronyms
Medical Terminology
All
All
Drugs
Medical Applications
Medical Calculators
Dilutions
Lab Values
Infectious Diseases
Oncology
Renal
Abbreviations
Acronyms
Medical Terminology
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
Home
Abbrev
Calculators
Med Terms
Dilutions
Drugs
I.Dx.
Labs
Medical
Finance
Oncology
Renal
RXList
Medline+
GRPH Blog
You are here
Home >
Medical Calculator
>
Diabetic Database
Diabetic Database
Diabetic Database
What is the
I
/carb ratio? What are the criteria for diagnosing diabetes? What are the usual target blood glucose levels? These are the type of questions this program was designed to answer.
Insulin Kinetics
Select an insulin (kinetics)
Aspart (Novolog)
Glargine (Lantus)
Lente
Lispro (Humalog)
NPH
Protamine Zinc
Regular insulin
Semilenti
Ultralente
Diabetic Guidelines
Diabetes - Pharmacotherapy
Mixing Insulin
Blood glucose goals
Insulin regimens
Daily insulin requirements
Premixed insulins
Adjusting insulin dosages
HbA1c vs 3 month glucose levels
Hypoglycemia
I/Carb ratio - 500 rule
Insulin Sensitivity Factor
Diagnosing diabetes
Type II diabetes
Type 2 Diabetes-Select option
Alpha-glucosidase Inhibitors
Biguanides
Meglitinides
Sulfonylureas
Thiazolidinediones
Lean Patient
Obese Patient
Renal Impairment
Liver Dysfunction
References:
American Diabetes Association (2002). Standards of medical care for patients with diabetes mellitus (Clinical Practice Recommendations 2002). Diabetes Care, 25(Suppl 1).
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329(14):977-86
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53
American Diabetes Association: Resource guide 2001. Diabetes Forecast (January).